A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy

Journal of the Neurological Sciences

Volumn 255, Issue 1-2, 2007, Pages 1-6

  Pineda, Arnold Angelo M ^a   Ogata, Katsuya ^a   Osoegawa, Manabu ^a   Murai, Hiroyuki ^a   Shigeto, Hiroshi ^a   Yoshiura, Takashi ^b   Tobimatsu, Shozo ^a   Kira, Jun ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Central nervous system; Chronic inflammatory demyelinating polyneuropathy; Motor evoked potentials; Somatosensory evoked potentials

Indexed keywords

CORTICOSTEROID; GADOLINIUM PENTETATE MEGLUMINE; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DEMYELINATING DISEASE; DISABILITY; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; GLOBAL NEUROLOGICAL DISABILITY SCORE; HUMAN; IMMUNOTHERAPY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; SCORING SYSTEM; SPINAL CORD; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; AGED; BRAIN; CENTRAL NERVOUS SYSTEM; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DRUG RESISTANCE; ELECTRODIAGNOSIS; EVOKED POTENTIALS, MOTOR; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; SPINAL CORD; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; WALLERIAN DEGENERATION;

EID: 33947205497     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.004     Document Type: Article

References (16)

1. Bouchard C., Lacroix C., Plante V., Adams D., Chedru F., Guglielmi J.M., et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52 (1999) 498-503
2. Rotta F.T., Sussman A.T., Bradley W.G., Ram Ayyar D., Sharma K.R., and Shebert R.T. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 173 (2000) 129-139
3. Ormerod I.E.C., Waddy H.M., Kermode A.G., Murray N.M.F., and Thomas P.K. Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 53 (1990) 789-793
4. Mendell J.R., Kolkin S., Kissel J.T., Weiss K.L., Chakeres D.W., and Rammohan K.W. Evidence from central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 37 (1987) 445-1291-4
5. Feasby T.E., Hahn A.F., Koopman W.J., and Lee D.H. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology 40 (1990) 476-478
6. Hawke S.H.B., Hallinan J.M., and Mcleod J.G. Cranial magnetic resonance imaging in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 53 (1990) 794-796
7. Iijima M., Yamamoto M., Hirayama M., Tanaka F., Kastuno M., Mori K., et al. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP. Neurology 64 (2005) 1471-1475
8. Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41 (1991) 617-618
9. Birouk N., Gouider R., Le Guern E., Gugenheim M., Tardieu S., Maisonobe T., et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication; clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120 (1997) 813-823
10. Suga R., Tobimatsu S., Kira J., and Kato M. Motor and somatosensory evoked potential findings in HLTV-1 associated myelopathy. J Neurol Sci 167 (1999) 102-106
11. Tobimatsu S., Sun S.-J., Fukui R., and Kato M. Effects of sex, height and age on motor evoked potentials with magnetic stimulation. J Neurol Sci 245 (1998) 256-261
12. Su J., Osoegawa M., Matsuoka T., Minohara M., Tanaka M., Ishizu T., et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 243 (2006) 21-30
13. Pakalnis A., Drake M.E., Barohn R.J., Chakeres D.W., and Mendell J.R. Evoked potentials in chronic inflammatory demyelinating polyneuropathy. Arch Neurol 45 (1988) 1014-1016
14. Dyck P.J., Litcy W.J., Kratz K.M., Suarez G.A., Low P.A., Pineda A.A., et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36 (1994) 838-845
15. Hughes R.A.C., Bensa S., Willison H.J., Van den Bergh P., Comi G., Illa I., Nobile-Orazio E., et al. Randomized controlled trial of intravenous immunoglobulin versus prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50 (2001) 195-201
16. Fee D.B., and Fleming J.O. Resolution of chronic inflammatory demyelinating poly-neuropathy-associated central nervous system lesions after treatment with intravenous immunoglobulin. JPNS 8 (2003) 155-158